29550
环己基氨基磺酸
≥98.0% (T)
别名:
环己氨磺酸, 环拉酸
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C6H13NO3S
化学文摘社编号:
分子量:
179.24
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
202-898-1
Beilstein/REAXYS Number:
2208885
MDL number:
产品名称
环己基氨基磺酸, ≥98.0% (T)
InChI key
HCAJEUSONLESMK-UHFFFAOYSA-N
InChI
1S/C6H13NO3S/c8-11(9,10)7-6-4-2-1-3-5-6/h6-7H,1-5H2,(H,8,9,10)
SMILES string
OS(=O)(=O)NC1CCCCC1
assay
≥98.0% (T)
form
solid
mp
~180 °C (dec.)
solubility
dioxane: 1 g/10 mL, clear, colorless (hot)
Quality Level
正在寻找类似产品? 访问 产品对比指南
General description
The N-cyclohexylsulfamic acid salts of well−known therapeutic agents were prepared.
存储类别
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Modification of physical properties of certain antitussive and antihistaminic agents by formation of N-cyclohexylsulfamate salts.
J A CAMPBELL et al.
Journal of pharmaceutical sciences, 51, 931-934 (1962-10-01)
Lin Yi et al.
Analytical and bioanalytical chemistry, 386(3), 666-674 (2006-05-26)
Characterizing the biological effects of metabolic transformations (or biotransformation) is one of the key steps in developing safe and effective pharmaceuticals. Sulfate conjugation, one of the major phase II biotransformations, is the focus of this study. While this biotransformation typically
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持